These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 27186640)

  • 1. Correction: Characterisation of Mesothelioma-Initiating Cells and Their Susceptibility to Anti-Cancer Agents.
    Pasdar EA; Smits M; Stapelberg M; Bajzikova M; Stantic M; Goodwin J; Yan B; Stursa J; Kovarova J; Sachaphibulkij K; Bezawork-Geleta A; Sobol M; Filimonenko A; Tomasetti M; Zobalova R; Hozak P; Dong LF; Neuzil J
    PLoS One; 2016; 11(5):e0156012. PubMed ID: 27186640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correction: MSLN gene silencing has an anti-malignant effect on cell lines overexpressing mesothelin deriving from malignant pleural mesothelioma.
    Melaiu O; Stebbing J; Lombardo Y; Bracci E; Uehara N; Bonotti A; Cristaudo A; Foddis R; Mutti L; Barale R; Gemignani F; Giamas G; Landi S
    PLoS One; 2017; 12(6):e0180317. PubMed ID: 28640856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction: Characterisation of liver fat in the UK Biobank cohort.
    Wilman HR; Kelly M; Garratt S; Matthews PM; Milanesi M; Herlihy A; Gyngell M; Neubauer S; Bell JD; Banerjee R; Thomas EL
    PLoS One; 2017; 12(4):e0176867. PubMed ID: 28445545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction: Apoptosis by [Pt(O,O'-acac)(γ-acac)(DMS)] requires PKC-δ mediated p53 activation in malignant pleural mesothelioma.
    Muscella A; Vetrugno C; Cossa LG; Antonaci G; Barca A; De Pascali SA; Fanizzi FP; Marsigliante S
    PLoS One; 2018; 13(2):e0193030. PubMed ID: 29432478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction: Generation and Characterisation of Cisplatin-Resistant Non-Small Cell Lung Cancer Cell Lines Displaying a Stem-Like Signature.
    Barr MP; Gray SG; Hoffmann AC; Hilger RA; Thomale J; O'Flaherty JD; Fennell DA; Richard D; O'Leary JJ; O'Byrne KJ
    PLoS One; 2020; 15(5):e0233739. PubMed ID: 32437439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction: Incidence and Predictors of Pregnancy among a Cohort of HIV-Positive Women Initiating Antiretroviral Therapy in Mbarara, Uganda.
    Kaida A; Matthews LT; Kanters S; Kabakyenga J; Muzoora C; Mocello AR; Martin JN; Hunt P; Haberer J; Hogg RS; Bangsberg DR
    PLoS One; 2013; 8(6):. PubMed ID: 29161730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction: Characterisation of morphological differences in well-differentiated nasal epithelial cell cultures from preterm and term infants at birth and one-year.
    Groves HE; Guo-Parke H; Broadbent L; Shields MD; Power UF
    PLoS One; 2019; 14(1):e0211611. PubMed ID: 30682198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction: The Nuclear IκB Family Protein IκBNS Influences the Susceptibility to Experimental Autoimmune Encephalomyelitis in a Murine Model.
    The
    PLoS One; 2015; 10(2):e0118159. PubMed ID: 25658316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction: Epidemiological, Clinical and Antiretroviral Susceptibility Characterization of Human Immunodeficiency Virus Subtypes B and Non-B in Pernambuco, Northeast Brazil.
    Lima K; de Souza Leal É; Cavalcanti AM; Salustiano DM; de Medeiros LB; da Silva SP; Lacerda HR
    PLoS One; 2016; 11(6):e0158192. PubMed ID: 27348744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction: Evidence for Reduced Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial.
    Sutherland KA; Parry CM; McCormick A; Kapaata A; Lyagoba F; Kaleebu P; Gilks CF; Goodall R; Spyer M; Kityo C; Pillay D; Gupta RK;
    PLoS One; 2016; 11(6):e0157094. PubMed ID: 27254277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correction: Surgical Stress Abrogates Pre-Existing Protective T Cell Mediated Anti-Tumor Immunity Leading to Postoperative Cancer Recurrence.
    Ananth AA; Tai LH; Lansdell C; Alkayyal AA; Baxter KE; Angka L; Zhang J; de Souza CT; Stephenson KB; Parato K; Bramson JL; Bell JC; Lichty BD; Auer RC
    PLoS One; 2016; 11(7):e0159471. PubMed ID: 27428021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction: Clinical Impact of MALDI-TOF MS Identification and Rapid Susceptibility Testing on Adequate Antimicrobial Treatment in Sepsis with Positive Blood Cultures.
    Verroken A; Defourny L; le Polain de Waroux O; Belkhir L; Laterre PF; Delmée M; Glupczynski Y
    PLoS One; 2016; 11(9):e0160537. PubMed ID: 27658295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction: nonequilibrium population dynamics of phenotype conversion of cancer cells.
    PLOS ONE Staff
    PLoS One; 2015; 10(3):e0118133. PubMed ID: 25811756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction: Actin Cytoskeleton Regulation of Epithelial Mesenchymal Transition in Metastatic Cancer Cells.
    Shankar J; Nabi IR
    PLoS One; 2015; 10(7):e0132759. PubMed ID: 26167914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction: Suppression of USP18 Potentiates the Anti-HBV Activity of Interferon Alpha in HepG2.2.15 Cells via JAK/STAT Signaling.
    Li L; Lei QS; Zhang SJ; Kong LN; Qin B
    PLoS One; 2016; 11(7):e0159019. PubMed ID: 27379545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction: Overcoming Resistance of Cancer Cells to PARP-1 Inhibitors with Three Different Drug Combinations.
    Yalon M; Tuval-Kochen L; Castel D; Moshe I; Mazal I; Cohen O; Avivi C; Rosenblatt K; Aviel-Ronen S; Schiby G; Yahalom J; Amariglio N; Pfeffer R; Lawrence YR; Toren A; Rechavi G; Paglin S
    PLoS One; 2016; 11(8):e0161799. PubMed ID: 27548061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction: The CARD9 Polymorphisms rs4077515, rs10870077 and rs10781499 Are Uncoupled from Susceptibility to and Severity of Pulmonary Tuberculosis.
    Streata I; Weiner J; Iannaccone M; McEwen G; Ciontea MS; Olaru M; Capparelli R; Ioana M; Kaufmann SH; Dorhoi A
    PLoS One; 2016; 11(10):e0165853. PubMed ID: 27783709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction: novel anti-nicotine vaccine using a trimeric coiled-coil hapten carrier.
    PLOS ONE Staff
    PLoS One; 2015; 10(3):e0122506. PubMed ID: 25807010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction: Correction: Pest susceptibility, yield and fiber traits of transgenic cotton cultivars in Multan, Pakistan.
    PLOS ONE Staff
    PLoS One; 2020; 15(11):e0242180. PubMed ID: 33152040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction: Application of a qPCR Assay in the Investigation of Susceptibility to Malaria Infection of the M and S Molecular Forms of An. gambiae s.s. in Cameroon.
    Boissière A; Gimonneau G; Tchioffo MT; Abate L; Bayibeki A; Awono-Ambéné PH; Nsango SE; Morlais I
    PLoS One; 2018; 13(5):e0196956. PubMed ID: 29715328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.